FRDM vs. SBIO

Last updated Jun 13, 2026

FRDM (Freedom 100 Emerging Markets ETF) and SBIO (ALPS Medical Breakthroughs ETF) are both exchange-traded funds - FRDM is a Emerging Markets Diversified fund tracking the Life + Liberty Freedom 100 Emerging Markets Index, while SBIO is a Health & Biotech Equities fund tracking the S-Network Medical Breakthroughs Index. Both are passively managed. Over the past 5 years, FRDM returned 18.68%/yr vs 1.91%/yr for SBIO. At a 0.41 correlation, their price movements are largely independent. FRDM charges 0.49%/yr vs 0.50%/yr for SBIO.

Performance

FRDM vs. SBIO - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Freedom 100 Emerging Markets ETF (FRDM) and ALPS Medical Breakthroughs ETF (SBIO). The values are adjusted to include any dividend payments, if applicable.

Returns By Period

In the year-to-date period, FRDM achieves a 40.13% return, which is significantly higher than SBIO's 3.01% return.

FRDM

• 1D: 0.49%
• 1M: 5.45%
• YTD: 40.13%
• 6M: 46.37%
• 1Y: 84.22%
• 3Y*: 34.29%
• 5Y*: 18.68%
• 10Y*: —

SBIO

• 1D: 1.29%
• 1M: -5.31%
• YTD: 3.01%
• 6M: 2.95%
• 1Y: 68.66%
• 3Y*: 17.63%
• 5Y*: 1.91%
• 10Y*: 9.19%

*Multi-year figures are annualized to reflect compound growth (CAGR)

FRDM vs. SBIO - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022	2021	2020	2019
FRDM Freedom 100 Emerging Markets ETF	40.13%	61.27%	1.70%	22.77%	-14.45%	6.13%	16.90%	12.23%
SBIO ALPS Medical Breakthroughs ETF	3.01%	55.07%	3.81%	8.68%	-28.08%	-17.55%	21.17%	25.51%

Correlation

The correlation between FRDM and SBIO is 0.41, which is low. Their price movements are largely independent, making them effective diversification partners.

	Correlation
Correlation (1Y) Calculated over the trailing 1-year period	0.41
Correlation (3Y) Calculated over the trailing 3-year period	0.39
Correlation (5Y) Calculated over the trailing 5-year period	0.41
Correlation (All Time) Calculated using the full available price history since May 23, 2019	0.41

FRDM vs. SBIO - Sectors Allocation Comparison

Sectors	FRDM	SBIO
Technology	41.1%	-
Financial Services	22.1%	-0.0%
Industrials	8.6%	-
Consumer Cyclical	7.8%	-
Basic Materials	7.4%	-
Communication Services	3.9%	-
Utilities	2.6%	-
Real Estate	2.5%	-
Consumer Defensive	2.2%	-
Healthcare	1.8%	100.0%
Energy	0.1%	-

Return for Risk

FRDM vs. SBIO — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

FRDM

FRDM Risk / Return Rank: 92
FRDM Sharpe Ratio Rank: 94
FRDM Sortino Ratio Rank: 90
FRDM Omega Ratio Rank: 92
FRDM Calmar Ratio Rank: 91
FRDM Martin Ratio Rank: 91

SBIO

SBIO Risk / Return Rank: 83
SBIO Sharpe Ratio Rank: 83
SBIO Sortino Ratio Rank: 81
SBIO Omega Ratio Rank: 71
SBIO Calmar Ratio Rank: 92
SBIO Martin Ratio Rank: 85

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

FRDM vs. SBIO - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Freedom 100 Emerging Markets ETF (FRDM) and ALPS Medical Breakthroughs ETF (SBIO). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.

	FRDM	SBIO	Difference
Sharpe ratio: Return per unit of total volatility	3.15	2.32	+0.83
Sortino ratio: Return per unit of downside risk	3.68	3.17	+0.51
Omega ratio: Gain probability vs. loss probability	1.54	1.37	+0.18
Calmar ratio: Return relative to maximum drawdown	5.02	5.45	-0.43
Martin ratio: Return relative to average drawdown	19.36	15.38	+3.98

FRDM vs. SBIO - Sharpe Ratio Comparison

The current FRDM Sharpe Ratio is 3.15, which is higher than the SBIO Sharpe Ratio of 2.32. The chart below compares the historical Sharpe Ratios of FRDM and SBIO, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.

Drawdowns

FRDM vs. SBIO - Drawdown Comparison

The maximum FRDM drawdown since its inception was -40.49%, smaller than the maximum SBIO drawdown of -63.06%. Use the drawdown chart below to compare losses from any high point for FRDM and SBIO.

Drawdown Indicators

	FRDM	SBIO	Difference
Max Drawdown Largest peak-to-trough decline	-40.49%	-63.06%	+22.57%
Max Drawdown (1Y) Largest decline over 1 year	-16.87%	-12.66%	-4.21%
Max Drawdown (3Y) Largest decline over 3 years	-16.87%	-42.44%	+25.57%
Max Drawdown (5Y) Largest decline over 5 years	-29.25%	-53.10%	+23.85%
Max Drawdown (10Y) Largest decline over 10 years	—	-63.06%	—
Current Drawdown Current decline from peak	-4.36%	-13.95%	+9.59%
Average Drawdown Average peak-to-trough decline	-7.09%	-28.41%	+21.32%
Ulcer Index Depth and duration of drawdowns from previous peaks	4.37%	4.51%	-0.14%

Volatility

FRDM vs. SBIO - Volatility Comparison

Freedom 100 Emerging Markets ETF (FRDM) has a higher volatility of 14.27% compared to ALPS Medical Breakthroughs ETF (SBIO) at 10.92%. This indicates that FRDM's price experiences larger fluctuations and is considered to be riskier than SBIO based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	FRDM	SBIO	Difference
Volatility (1M) Calculated over the trailing 1-month period	14.27%	10.92%	+3.35%
Volatility (6M) Calculated over the trailing 6-month period	24.39%	22.88%	+1.51%
Volatility (1Y) Calculated over the trailing 1-year period	26.86%	29.77%	-2.91%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	21.35%	33.59%	-12.24%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	23.09%	33.18%	-10.09%

FRDM vs. SBIO - Expense Ratio Comparison

FRDM has a 0.49% expense ratio, which is lower than SBIO's 0.50% expense ratio.

Dividends

FRDM vs. SBIO - Dividend Comparison

FRDM's dividend yield for the trailing twelve months is around 1.56%, while SBIO has not paid dividends to shareholders.

Position	TTM	2025	2024	2023	2022	2021	2020	2019	2018	2017
FRDM Freedom 100 Emerging Markets ETF	1.56%	2.26%	2.53%	2.66%	2.72%	2.17%	1.11%	1.07%	0.00%	0.00%
SBIO ALPS Medical Breakthroughs ETF	0.00%	0.00%	3.55%	0.22%	0.00%	0.00%	0.00%	0.04%	2.79%	1.77%

Frequently Asked Questions

Can I hold both FRDM and SBIO in my portfolio?

FRDM and SBIO have a correlation of 0.41, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

Which is riskier, FRDM or SBIO?

FRDM has higher volatility (14.27%) compared to SBIO (10.92%). In terms of maximum drawdown, FRDM dropped -40.49% vs SBIO's -63.06%.

Which ETF is better, FRDM or SBIO?

On 5-year performance, FRDM leads with 18.68% vs 1.91% for SBIO. On fees, FRDM is cheaper at 0.49% per year. On volatility, SBIO has been the lower-risk option at 10.92%. The better choice depends on whether you care most about return, fees, risk, or income.

Which ETF has performed better, FRDM or SBIO?

Over the 5-year period, FRDM has performed better with a 18.68% return vs 1.91%. Past performance does not guarantee future results, so compare this with risk, fees, and fund exposure.

Which ETF is cheaper, FRDM or SBIO?

FRDM is cheaper with a 0.49% expense ratio, compared with 0.50% for SBIO.

Which ETF pays a higher dividend yield, FRDM or SBIO?

FRDM has the higher dividend yield at 1.56%, compared with 0.00% for SBIO.

What is the main difference between FRDM and SBIO?

FRDM is categorized as Emerging Markets Diversified, while SBIO is Health & Biotech Equities. FRDM tracks Life + Liberty Freedom 100 Emerging Markets Index, while SBIO tracks S-Network Medical Breakthroughs Index. They also come from different issuers: Freedom Funds and SS&C. Their fees differ too: 0.49% for FRDM and 0.50% for SBIO.

Which has better risk-adjusted returns?

FRDM currently has the higher Sharpe Ratio (3.15 vs 2.32), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.